Please note: This website includes an accessibility system. Press Control-F11 to adjust the website to the visually impaired who are using a screen reader; Press Control-F10 to open an accessibility menu.

by

Homepage
Tags search
Biopharma

CTech 24/7

22:04 Google’s $32 billion acquisition of Wiz draws antitrust attention

More stories in CTech

Biopharma

6 stories about Biopharma

Biopharma company Short Wave partnering in clinical trial for eating disorders with Sheba Fund
16.08.22|CTechThe trial will study the safety and feasibility of psilocybin-assisted psychotherapy for the treatment of anorexia nervosa
SpliSense secures $28.5 million in funding to advance mRNA-altering pipeline for treatment of CF
13.05.21|Meir OrbachThe Israeli startup was founded by Prof. Batsheva Kerem, a renowned geneticist from the Hebrew University of Jerusalem, and its technology is based on her research
Israeli biopharma startup Omnix Medical awarded €10.8 million from EU to fight drug-resistant bacteria
26.01.21|Meir OrbachThe novel agents developed by Omnix are designed as an alternative to classical antibiotics
Nasdaq-Listed Biopharma Company Chiasma Raises $34.5 Million in Public Offering
09.04.19|CTechChiasma develops octreotide capsules for the treatment of acromegaly, a rare, chronic disease typically caused by a benign tumor of the pituitary gland
Gastro Treatment Company RedHill Wants to Raise $117 on Nasdaq
24.07.18|Lilach BaumerThe Tel Aviv-headquartered company announced on Monday that Nasdaq approved its listing on its second tier, the Global Market. RedHill's ADSs were previously listed on Nasdaq Capital Market
RedHill's Public Offering Spooks Investors, Sends Stock Down
09.11.17|Dror ReichThe Nasdaq-listed biopharmaceutical company priced its shares at $5.5 per American Depositary Share, a third of its 2015 public offering price, and dropped nearly 30% by Wednesday market close

About CTech Terms of Use Privacy Policy

Back to Top